Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 9Ovarian Neoplasms 5Neutropenia 4Breast Neoplasms 4Adenocarcinoma, Bronchiolo-Alveolar 4Adenocarcinoma of Lung 4Small Cell Lung Carcinoma 3Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Previously Treated Non Small Cell Lung Cancer 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Non-Hodgkin 1Head and Neck Neoplasms 1Fever 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Renal Cell 1Anemia 1

Interventions

pegfilgrastim 1adavosertib 1Antimitotic Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Previously Treated Non Small Cell Lung Cancer × pegfilgrastim × Thoracic × Clear all
NCT02087176 2016-06-14

A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer

AstraZeneca

Phase 2 Terminated
48 enrolled 11 charts
Thoracic

Previously Treated Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡